Bloodborne diseases spread when pathogens living in one person’s blood enter another person’s bloodstream, typically through a break in the skin or contact with a mucous membrane. The major bloodborne pathogens are hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV), though others exist. The common thread across every transmission route is that infected blood has to find a way past the body’s outer barriers, and the specific ways that happens range from the obvious (a contaminated needle) to the surprising (a splash to the eye).
Needlestick Injuries and Percutaneous Exposure
The most studied route of bloodborne transmission in healthcare is the needlestick injury, where a contaminated sharp object punctures the skin. A review of needlestick cases at one center found that roughly one in five source patients carried at least one bloodborne pathogen, though the actual rate of transmission from a single stick is much lower than the rate of exposure. In that analysis, one case of hepatitis C transmission occurred and was successfully treated, while no HIV infections resulted, partly because post-exposure prophylaxis was started quickly for those at risk.1PubMed Central. The management of needlestick injuries The risk per individual needlestick varies enormously depending on the pathogen: HBV carries the highest single-exposure risk of the three major bloodborne viruses, followed by HCV, with HIV being the lowest. Factors like the depth of the wound, whether the needle was hollow-bore (carrying more blood), and the viral load in the source patient all influence whether a single puncture leads to infection.
Shared Needles and Injection Drug Use
Outside of healthcare, the most efficient route of bloodborne transmission is sharing injection equipment. When people who inject drugs reuse or share syringes, cookers, filters, or rinse water, even trace amounts of blood left behind can carry enough virus to infect. HCV is especially persistent in this setting. A long-running needle exchange program in Sweden tracked participants over years and found that HIV incidence stayed very low and HBV incidence declined thanks to vaccination. But HCV transmission remained stubbornly high, with an incidence of about 31 to 38 per 100 person-years, and most seroconversions happened in the first year after enrolling in the program.2PubMed. Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program That gap between HIV and HCV tells you something about how resilient HCV is: it survives in smaller quantities of blood and on equipment surfaces far more readily than HIV does.
Needle exchange programs do reduce risky behaviors. Participants in a program in Fresno, California, reported significant decreases in needle sharing and increased use of clean equipment.3PubMed Central. The Significance of Harm Reduction as a Social and Health Care Intervention for Injecting Drug Users: An Exploratory Study of a Needle Exchange Program in Fresno, California The problem is that HCV’s extraordinary infectiousness means even modest lapses in sterile technique, sharing a piece of cotton or a spoon, can keep transmission going even when needles themselves are clean.
Sexual Transmission
Sex can transmit bloodborne infections, but the mechanism still comes back to blood. HIV transmits efficiently through sexual contact partly because of the virus’s ability to infect mucosal immune cells directly, but hepatitis C, historically considered only a blood-to-blood pathogen, has increasingly been recognized as sexually transmissible under certain conditions. Research on HCV transmission among HIV-positive men who have sex with men found that mucosal trauma and rectal bleeding during sex significantly increased the likelihood of permucosal HCV transmission.4Open Forum Infectious Diseases. Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control Study In other words, HCV sexual transmission often still depends on blood exposure through micro-injuries in mucosal surfaces. Hepatitis B, by contrast, is present in semen and vaginal fluids at levels high enough to transmit without visible blood, which is one reason HBV vaccination is recommended so broadly.
Mother-to-Child Transmission
A pregnant person carrying a bloodborne virus can pass it to their baby during pregnancy, labor, or breastfeeding. With HBV, the placenta is not a perfect barrier. Research shows that placental trophoblast cells can become infected with HBV, and the likelihood of this happening depends on factors like the mother’s viral load, the trophoblast cells’ stage of development, and the molecular pathways the virus exploits to enter those cells.5PubMed Central. Intrauterine Infection and Mother-to-Child Transmission of Hepatitis B Virus: Route and Molecular Mechanism Without intervention, vertical HBV transmission rates can be very high, particularly when the mother has a high viral load. This is why newborns in many countries receive an HBV vaccine dose within hours of birth.
The placenta blocks some pathogens better than others. A review of how different infections cross the placental barrier noted that certain viruses gain access by infecting trophoblast cells directly, while others may use alternative cellular receptors that are not yet fully mapped.6PubMed Central. Mechanisms and evidence of vertical transmission of infections in pregnancy including SARS-CoV-2s For HIV, antiretroviral therapy during pregnancy has reduced mother-to-child transmission to below two percent in well-resourced settings, turning what was once a near-certainty into a rare event.
Blood Transfusions and the Modern Blood Supply
Contaminated blood transfusions were once a major route of bloodborne disease. The modern era of transfusion medicine grew out of World War II, and the hazards, particularly hepatitis, became apparent soon after. Over the following decades, HIV emerged as a devastating transfusion-transmitted infection before screening tests were developed. Specific donor screening assays and other interventions have since minimized infectious disease transmission through blood products, though they have not eliminated it entirely.7PubMed Central. The hazards of blood transfusion in historical perspective
The introduction of nucleic acid testing, or NAT, was a major leap. Traditional antibody screening misses infections during the “window period,” the early days or weeks after someone is infected when the immune system has not yet produced detectable antibodies. NAT detects the virus’s genetic material directly, drastically shortening that window.8PubMed Central. Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety In South Africa, where donor-level NAT was evaluated across more than 700,000 donations, the estimated residual risk of receiving an HIV-infected unit dropped to roughly 1 in 479,000, HBV to about 1 in 61,500, and HCV to roughly 1 in 21 million.9PubMed. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa In countries with more extensive screening, the risk of HCV and HIV from transfusion has been estimated at less than one transmission per two to three million donations.10Seminars in Hematology. Emerging infectious diseases that threaten the blood supply
Beyond screening, pathogen inactivation technologies aim to destroy viruses and bacteria in donated blood components. These methods work well for plasma and platelets, effectively inactivating most pathogens with the exception of some hard-to-kill nonenveloped viruses. Clinical trials and monitoring programs suggest the slight loss of blood component potency from the treatment is rarely clinically meaningful.11PubMed. Component pathogen inactivation: a critical review Inactivation methods for red blood cells are still in development, so screening remains the primary defense for those products.12PubMed Central. Pathogen inactivation technologies for cellular blood components: an update
Tattoos, Piercings, and Informal Settings
Any procedure that breaks the skin with a reusable tool can transmit bloodborne pathogens if equipment is not properly sterilized. A systematic review and meta-analysis of 40 studies found that body piercing was significantly associated with both HBV and HCV transmission, roughly doubling the odds of infection for each.13PubMed Central. Transmission of Hepatitis B and C Virus Infection Through Body Piercing: A Systematic Review and Meta-Analysis But the risk depends heavily on where and how the work is done. A critical review of the tattooing and piercing literature found no clear increase in HCV risk from professional parlors that follow standard infection control. The danger spikes in informal settings: tattoos applied in prisons or by friends carried two to nearly four times the odds of HCV infection compared to people without tattoos.14PubMed Central. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review The takeaway is that the procedure itself is not inherently dangerous; the infection control environment makes the difference.
Healthcare Lapses and Contaminated Equipment
Some of the most dramatic bloodborne disease outbreaks have occurred not from needlesticks but from contaminated multidose medication vials. In one hemodialysis unit, a healthcare worker accidentally stuck herself with a needle before drawing up local anesthetic from a shared vial, contaminating it with HBV. Ten of eleven susceptible patients who later received injections from that vial became infected, an attack rate of 91 percent.15PubMed. Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit
That case is not an isolated example. In Sweden, two women with no conventional risk factors for hepatitis B were traced to a local anesthetic multidose vial that had been contaminated with an HBV strain circulating among people who inject drugs in the community. The investigators concluded that multidose vials have no place in modern healthcare.16PubMed. Nosocomial transmission of hepatitis B virus infection through multiple-dose vials Similar patterns have been documented with HCV: an outbreak at an outpatient clinic traced 12 HCV transmissions to unsafe handling of multidose anesthetic vials and possible needle reuse.17PubMed. Hepatitis C transmission due to contamination of multidose medication vials: summary of an outbreak and a call to action These incidents tend to result from lapses in basic technique rather than from exotic or unpredictable events, which makes them preventable.
Splash Exposures and Mucous Membranes
You do not need a puncture wound to be at risk. Mucous membranes, particularly the eyes, carry enough blood vessels and permeable tissue to allow viral entry. A documented case involved a 23-year-old nurse in a hemodialysis unit who got blood from an HCV-positive patient splashed into her eyes. Six months later, she developed symptoms and tested positive for both HCV antibodies and HCV RNA.18PubMed. Transmission of hepatitis C by blood splash into conjunctiva in a nurse Cases like this are rare compared to needlestick injuries, but they reinforce why healthcare settings stock eye protection and face shields, especially in areas where blood splashes are likely.
Bites, Saliva, and What Does Not Spread These Diseases
One of the most common questions about bloodborne diseases is whether they can spread through casual contact, saliva, or insect bites. The short answer for saliva is: almost never, and only when blood is involved. While both HBV DNA and HCV RNA can be detected in saliva, the amounts are generally too low to transmit infection unless the saliva is visibly contaminated with blood.19PubMed. A review of risk of hepatitis B and C transmission through biting or spitting The risk from spitting is considered negligible for HCV and very low for HBV.
Human bites add a layer of complexity because they can draw blood from both parties. A review of bite-related bloodborne pathogen risk noted that all biters and bite victims should be evaluated for hepatitis B, since HBV can transmit through mucosal exposure and, rarely, through saliva that does not visibly contain blood. For HCV and HIV, transmission from biter to victim is negligible unless the saliva is bloody. But the reverse matters too: the biter’s mouth is invariably exposed to the victim’s blood, so the person who was bitten should also be tested as a potential source of infection.20PubMed. Human bites: bloodborne pathogen risk and postexposure follow-up algorithm
Why Insects Do Not Transmit HIV or Hepatitis
People have wondered since the early days of the HIV epidemic whether mosquitoes or other blood-feeding insects could spread the virus. Researchers have looked into this carefully. HIV was found to remain viable inside African soft ticks for up to 10 days and in the gut of bedbugs for up to 8 days, so the virus does not die instantly in arthropods.21PubMed Central. Why is HIV not vector‐borne? But survival inside an insect is not the same as transmission. Mosquitoes inject saliva when they bite, not the contents of their gut. They also carry extremely small volumes of blood. HIV does not replicate in insect cells, so whatever tiny amount gets ingested simply degrades. The combination of minuscule blood volume, lack of viral replication, and the mechanics of how insects feed means that no bloodborne pathogen of the HBV/HCV/HIV type has ever been confirmed to transmit through insect bites. This is fundamentally different from diseases like malaria or dengue, where the pathogen actively reproduces inside the mosquito and is injected in saliva.
How Long Pathogens Survive Outside the Body
The persistence of bloodborne viruses on surfaces is relevant for anyone handling sharps, cleaning up blood spills, or working in environments where dried blood may be present. HIV dried onto glass remained infectious for several days in laboratory conditions, though cell-associated virus lost infectivity faster than free virus.22PubMed Central. Survival of human immunodeficiency virus in suspension and dried onto surfaces HBV is tougher still, surviving on surfaces for at least a week and sometimes longer. HCV falls somewhere in between.
Other bloodborne or blood-associated viruses can be remarkably durable. Hepatitis E virus remained infectious on most surfaces for up to four weeks at room temperature and up to eight weeks when kept cool, with the highest stability on plastic surfaces and the lowest on wood.23PubMed Central. Stability of Hepatitis E Virus After Drying on Different Surfaces Ebola virus persisted longer on hospital surfaces under climate-controlled conditions than under the hotter, drier conditions typical of West Africa, and it survived longer in liquid blood than in dried blood.24PubMed Central. Ebola Virus Stability on Surfaces and in Fluids in Simulated Outbreak Environments These findings underscore why standard disinfection of surfaces and prompt cleanup of blood spills matter, even when the blood appears dry.
What To Do After a Potential Exposure
If you experience a needlestick, sexual exposure, or other event that may have introduced someone else’s blood into your body, timing matters enormously. For HIV, post-exposure prophylaxis (PEP) is a course of antiretroviral medications that can prevent the virus from establishing a permanent infection. Modeling research found that early initiation is the most important factor in PEP success. A two-drug regimen may not protect adequately if started more than an hour after exposure, but adding a potent third drug extends the effective window: over 90 percent efficacy was achievable when a three-drug PEP regimen was started within 48 hours and taken for at least 14 to 28 days.25PubMed Central. Modelling the impact of initiation delay, duration and prior PrEP on the efficacy of post-exposure prophylaxis containing a tenofovir/emtricitabine backbone The key message is to seek medical attention immediately after a suspected exposure rather than waiting to see what happens.
For hepatitis B, post-exposure treatment involves hepatitis B immunoglobulin and vaccination (for those not already vaccinated), ideally within 24 hours. For hepatitis C, there is no equivalent prophylaxis, but early detection through follow-up testing allows treatment with direct-acting antivirals, which now cure more than 95 percent of infections. The absence of an HCV vaccine or post-exposure drug makes prevention, through safe injection practices, proper equipment sterilization, and barrier precautions, the primary line of defense.
How Bloodborne Pathogens Jump Between Species
The bloodborne viruses that affect humans today did not originate in our species. HIV descended from simian immunodeficiency viruses that crossed from nonhuman primates to humans, most likely through hunting and butchering of bushmeat or through bites and scratches from infected animals. Similar cross-species jumps have been documented for simian T-cell lymphotropic virus and simian foamy virus.26AIDS. Cross-species transmission of simian retroviruses: how and why they could lead to the emergence of new diseases in the human population Exposure alone is not enough, though. For a virus to make a successful species jump, molecular compatibility between the virus and the new host’s cells is essential, and then the virus must become transmissible between humans. Most animal-to-human spillover events are dead ends. The rare ones that are not, like the SIV strains that became HIV, reshape public health for generations.